Cervical Esophageal Cancers: Challenges and Opportunities
- 4 April 2019
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 21 (5) , 46
Abstract
Cervical esophageal cancers (CECs) are a rare subset of esophageal cancers that are distinct in their management and outcomes. This review explores current data on the optimal management of this disease.Keywords
This publication has 35 references indexed in Scilit:
- Definitive radiotherapy for cervical esophageal cancerHead & Neck, 2013
- Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagusDiseases of the Esophagus, 2013
- Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trialThe Lancet Oncology, 2013
- Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After ChemoradiotherapyThe Annals of Thoracic Surgery, 2013
- Preoperative Chemoradiotherapy for Esophageal or Junctional CancerNew England Journal of Medicine, 2012
- Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck CancerNew England Journal of Medicine, 2007
- Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102Journal of Clinical Oncology, 2007
- Epidemiology of head and neck cancer in the United StatesOtolaryngology–Head and Neck Surgery, 2006
- Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the EsophagusJournal of Clinical Oncology, 2005
- Management of cervical esophageal carcinomaSeminars in Radiation Oncology, 1994